Gombos, A., Venet, D., Ameye, L., Vuylsteke, P., Neven, P., Richard, V., . . . Gebhart, G. (2021). FDG positron emission tomography imaging and ctDNA detection as an early dynamic biomarker of everolimus efficacy in advanced luminal breast cancer. Nature Portfolio.
Cita Chicago Style (17a ed.)Gombos, Andrea, et al. FDG Positron Emission Tomography Imaging and CtDNA Detection as an Early Dynamic Biomarker of Everolimus Efficacy in Advanced Luminal Breast Cancer. Nature Portfolio, 2021.
Cita MLA (8a ed.)Gombos, Andrea, et al. FDG Positron Emission Tomography Imaging and CtDNA Detection as an Early Dynamic Biomarker of Everolimus Efficacy in Advanced Luminal Breast Cancer. Nature Portfolio, 2021.
Precaución: Estas citas no son 100% exactas.